158 related articles for article (PubMed ID: 38334471)
21. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
22. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
[TBL] [Abstract][Full Text] [Related]
23. Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years.
Acosta Ruiz V; Dahlman P; Brekkan E; Lönnemark M; Magnusson A
Acta Radiol; 2024 Mar; 65(3):294-301. PubMed ID: 32910687
[TBL] [Abstract][Full Text] [Related]
24. Safety of CT-Guided Microwave Ablation of Subcardiac Liver Tumors.
Johnson W; Weekley A; Suz P; Parikh N; El-Haddad G; Mhaskar R; Kis B
Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1693-1700. PubMed ID: 35941243
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous microwave ablation of renal masses in a UK cohort.
John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
[TBL] [Abstract][Full Text] [Related]
26. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma.
Yu J; Zhang G; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Li QY; Mu MJ; Li X
Abdom Imaging; 2015 Oct; 40(8):3248-56. PubMed ID: 26288264
[TBL] [Abstract][Full Text] [Related]
27. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
28. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
30. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
Guo J; Arellano RS
J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
[No Abstract] [Full Text] [Related]
32. The efficacy and safety of microwave ablation in patients with retroperitoneal metastases.
Wei Z; Ye X; Yang X; Zheng A; Huang G; Dong S; Li W; Wang J; Han X; Meng M; Ni Y
Int J Hyperthermia; 2018 Nov; 34(7):1053-1060. PubMed ID: 29082799
[TBL] [Abstract][Full Text] [Related]
33. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
[TBL] [Abstract][Full Text] [Related]
34. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
36. A comparative analysis of thermal ablation techniques in the treatment of primary and secondary lung tumors: a single-center experience.
Grasso RF; Bernetti C; Pacella G; Altomare C; Castiello G; Andresciani F; Sarli M; Zobel BB; Faiella E
Radiol Med; 2022 Jul; 127(7):714-724. PubMed ID: 35701683
[TBL] [Abstract][Full Text] [Related]
37. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.
Castle SM; Salas N; Leveillee RJ
Urology; 2011 Apr; 77(4):792-7. PubMed ID: 21324512
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma.
Maciolek KA; Abel EJ; Best SL; Emamekhoo H; Averill SL; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Wells SA
Abdom Radiol (NY); 2018 Sep; 43(9):2446-2454. PubMed ID: 29464274
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]